SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N HSQC20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 600
22D 1H-13C HSQC aliphatic20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 600
32D 1H-13C HSQC aromatic20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 600
43D HNCA20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 600
53D HNCACB20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 600
73D CBCA(CO)NH20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 600
63D 15N resolved [1H,1H]-NOESY20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 800
93D 13Caliphatic resolved [1H,1H]-NOESY20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 800
83D 13Caromatic resolved [1H,1H]-NOESY20 mM sodium phosphate, 50 mM sodium chloride, 0.5 mM [U-13C; U-15N] Human liver fatty acid binding protein (hFABP1), 90% H2O/10% D2O90% H2O/10% D2O20 mM Sodium Phosphate, 50 mM NaCl mM5.51 atm308Bruker AVANCE III 800
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE III600
2BrukerAVANCE III800
NMR Refinement
MethodDetailsSoftware
molecular dynamicsthe structures are based on a total of 2553 NOE-derived distance constraints, 202 dihedral angle constraints, 58 distance restraints from hydrogen bondsPrime
Restraint energy minimizationOPALpOPALp
NMR Ensemble Information
Conformer Selection Criteriastructures with acceptable covalent geometry
Conformers Calculated Total Number40
Conformers Submitted Total Number10
Representative Model1 (closest to the average)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpinBruker Biospin
2processingTopSpinBruker Biospin
3chemical shift assignmentCARAKeller and Wuthrich
4peak pickingCARAKeller and Wuthrich
5structure calculationCYANAGuntert, Mumenthaler and Wuthrich
6structure calculationUNIO10-ATNOS/CANID2.0.2Dr. Torsten Herrmann
7refinementOPALpKoradi et al, 2000
8refinementPrimePrime, Schrodinger, LLC, New York, NY, 2018